Follow-The-Filings

Security · featured owners

MLYS Mineralys Therapeutics Inc.

COM Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.2%
  • $1M
  • 1 add

Who owns this now

Largest portfolio weights among featured holders · max 0.2% (Nathan Fischel - Dafna Ca...) · not free-float ownership

  1. Nathan Fischel add 0.23%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Nathan Fischel - Dafna Capital Management 2026 Q2 0.23% Add +15.6% 44,490 $1M history

1 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Net income -$71.9M -$177.81M -$154.65M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $249.1M $205.35M $661.39M
Total non-current assets * $2.53M $552,000 $420,000
Total assets $251.64M $205.9M $661.81M
Total current liabilities $10.48M $14.65M $15.11M
Total equity $241.15M $191.26M $646.69M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$81.17M -$166.31M -$142.42M
Cash from investing -$160.47M $114.96M -$389.75M
Cash from financing $203.25M $116.14M $591M
Net change in cash -$38.4M $64.79M $58.83M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders